A drug designed to block ECF transporters would attack the bacteria while leaving human cells largely unaffected, substantially reducing the risk of side effects. A research team has succeeded in developing exactly such a drug candidate.
A new study has developed a high-resolution, county-level inventory of veterinary antibiotic emissions across China, offering researchers and policymakers a clearer picture of where these pollutants originate and where they may accumulate.
Biomedical engineers have developed a fully automated workflow that simplifies and accelerates the preparation of bacterial samples for genetic sequencing. The method streamlines a critical bottleneck in the genetic sequencing process.
Scientists have systematically elucidated the complete mechanism through which the fructooligosaccharide-induced “Ligilactobacillus murinus-Anaerotruncus colihominis” axis reduces uric acid (UA) levels and protects the kidneys.
Researchers found that extreme changes, both due to weather and human activity, are reshaping microbial communities in the Great Salt Lake that form the base for a large food web.
Scientists have read the full genetic code of bacteria from the salt lakes of Wadjemup (Rottnest Island), giving them their clearest picture yet of how these tiny organisms could be used to make biodegradable plastic.
A drug designed to block ECF transporters would attack the bacteria while leaving human cells largely unaffected, substantially reducing the risk of side effects. A research team has succeeded in developing exactly such a drug candidate.
A new study has developed a high-resolution, county-level inventory of veterinary antibiotic emissions across China, offering researchers and policymakers a clearer picture of where these pollutants originate and where they may accumulate.
Scientists have systematically elucidated the complete mechanism through which the fructooligosaccharide-induced “Ligilactobacillus murinus-Anaerotruncus colihominis” axis reduces uric acid (UA) levels and protects the kidneys.
ABM, a leading international provider of facility, engineering, and infrastructure solutions, has secured a major multi-site services agreement with a leading global life sciences company operating manufacturing facilities across Ireland.
At ASM Microbe 2026, Bruker Corporation’s Microbiology & Infection Diagnostics (BMID) division demonstrated its expanding portfolio and innovations across microbial identification, sepsis diagnostics, molecular testing, and NGS workflows, advancing clinical research, and faster, actionable infectious disease diagnostics.
Biomedical engineers have developed a fully automated workflow that simplifies and accelerates the preparation of bacterial samples for genetic sequencing. The method streamlines a critical bottleneck in the genetic sequencing process.
A new artificial intelligence model called Evo 2 can analyze and generate DNA sequences across bacteria, archaea, plants, animals, and other forms of life, marking a major step toward a unified AI system for biology.
A new study reports a self-powered platform that links electrically assisted forward osmosis (eFO) with a microbial desalination cell (MDC), allowing electricity produced by wastewater-fed microbes to drive nutrient and water recovery.
BugBiome has secured a £500,000 grant from Innovate UK to fund a collaborative project to develop a new biological insecticide to control cabbage stem flea beetles (CSFB) in oilseed rape.
Two researchers are teaming up to build foundational knowledge concerning leishmaniasis, a common, but neglected protozoan parasitic disease. The project combines research into the cell biology of membrane repair with parasitology knowledge.
Researchers creating the first comprehensive fungal EV atlas will investigate vesicles produced by fungi belonging to the Candida, Aspergillus and Cryptococcus genera, while also working to standardise the methods used for their isolation and analysis.